Daptomycin

NDC 63323-371 · Fresenius Kabi USA, LLC

FDA carries 2 listing records for this NDC; the most recent is shown.

Generic nameDaptomycin

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)DAPTOMYCIN

Strength500 mg/10mL

Pharmacologic classLipopeptide Antibacterial [EPC], Lipopeptides [CS]

Marketing categoryANDA

Packages

63323-371-10 — 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-371-10) / 10 mL in 1 VIAL, SINGLE-DOSE

63323-371-19 — 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-371-19) / 10 mL in 1 VIAL, SINGLE-DOSE

FDA lists these products with the same active ingredient.

25021-174 — daptomycin, 25021-179 — Daptomycin, 31722-215 — Daptomycin, 31722-216 — Daptomycin, 42023-295 — Daptomycin, 43598-413 — Daptomycin, 43598-476 — Daptomycin, 55150-344 — DAPTOMYCIN, 60505-6229 — Daptomycin, 60977-145 — daptomycin, 67184-0549 — Daptomycin, 67457-813 — daptomycin, 67457-941 — daptomycin, 68001-376 — Daptomycin, 70377-093 — Daptomycin, 70436-033 — daptomycin, 70511-182 — Daptomycin, 70594-034 — Daptomycin, 70594-053 — Daptomycin, 70594-060 — daptomycin, +25 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.